Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
This study has been completed.
Study NCT00234702   Information provided by Shire Pharmaceutical Development
First Received: October 5, 2005   Last Updated: January 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Diseases
Additional conditions recognized in this trial
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Failure
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Lanthanum carbonate
Placebo
Sponsors listed in this trial
Shire Pharmaceutical Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services